Moolec Science (MLEC) Shares Outstanding (Weighted Average) (2022 - 2025)
Moolec Science's (MLEC) quarterly Shares Outstanding (Weighted Average) came in at $1.1 billion in Q4 2025, up 5621.01% year-on-year from $19.0 million in Q4 2024, and little changed quarter-over-quarter from $1.1 billion in Q2 2025.
Moolec Science (MLEC) Shares Outstanding (Weighted Average) (2022 - 2025) Analysis & Trends
Moolec Science has disclosed Shares Outstanding (Weighted Average) across 4 years of filings, most recently posting $1.1 billion for Q4 2025.
- Shares Outstanding (Weighted Average) for Q4 2025 came in at $1.1 billion, up 5621.01% year-over-year; the trailing twelve-month figure through Dec 2025 was $1.1 billion (up 5621.01% YoY), and the FY2025 annual result was $1.1 billion, up 181924.14% from the prior year.
- Shares Outstanding (Weighted Average) came in at $1.1 billion for Q4 2025 at Moolec Science, roughly flat from $1.1 billion in the prior quarter.
- In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $2.2 billion in Q2 2022 to a low of $20.0 in Q3 2022.
- The 4-year median for Shares Outstanding (Weighted Average) is $43.0 million (2023), against an average of $333.6 million.
- Peak annual rise in Shares Outstanding (Weighted Average) reached 334984810.0% in 2023, while the deepest fall reached 99.79% in 2023.
- Moolec Science's Shares Outstanding (Weighted Average) stood at $1570.0 in 2022, then soared by 4267223.69% to $67.0 million in 2023, then tumbled by 71.58% to $19.0 million in 2024, then jumped by 5621.01% to $1.1 billion in 2025.
- The last three Shares Outstanding (Weighted Average) figures came in at $1.1 billion (Q4 2025), $1.1 billion (Q2 2025), and $19.0 million (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Weighted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | 185,491.37 Bn |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | 400.00 Bn |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | 4,489.46 Bn |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 100.00 Bn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | 118.76 Bn |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | 417.01 Bn |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | 68.88 Bn |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 254.10 Mn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | 928.40 Mn |
| 10 | Moolec Science | 6.98 Bn | 6.98 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.09 Bn |
| Jun 30, 2025 | 1.09 Bn |
| Dec 31, 2024 | 19.04 Mn |
| Sep 30, 2024 | 69.16 Mn |
| Jun 30, 2024 | 598,369.00 |
| Mar 31, 2024 | 67.00 Mn |
| Dec 31, 2023 | 67.00 Mn |
| Sep 30, 2023 | 67.00 Mn |
| Jun 30, 2023 | 4.59 Mn |
| Mar 31, 2023 | 1,470.00 |
| Dec 31, 2022 | 1,570.00 |
| Sep 30, 2022 | 20.00 |
| Jun 30, 2022 | 2.20 Bn |
| Mar 31, 2022 | 100.00 |